Bioimpedance Analyzer Market Report

The continuous advancements in the field of technology and medicine help the bioimpedance analyser market to grow. The development of multi frequency bioimpedance analysers and dual frequency bioimpedance analysers allow for more accurate and detailed measurements of body composition, leading to increased adoption among healthcare professionals, fitness enthusiasts, and individuals seeking to monitor their health. Integration of artificial intelligence, machine learning, neural networks and internet of things algorithms into bioimpedance analysis systems enables automated data analysis, predictive modelling, and personalized recommendations, enhancing diagnostic accuracy. The advancement of precision medicine methods, coupled with the integration of genomics and metabolomics creates opportunities for bioimpedance analysers to contribute to personalized healthcare interventions and treatment strategies.

Although information such as body composition and hydration status are obtained by bioimpedance analysers, their accuracy may vary depending on age, gender and hydration level. The accuracy of small analysers may not be as precise as computed tomography (CT) and magnetic resonance imaging (MRI) which are preferred by healthcare professionals. Moreover, the slightly accurate bigger analysers become costly for fitness centres and health clubs. The minimum cost of single accurate bioimpedance analyser can go up to US$ 21,000. Additionally, inability of many bioimpedance analysers to exactly locate fat in the body can prevent the analyser market from growing. There may be a lack of awareness and training among healthcare professionals, fitness trainers, and consumers regarding the benefits, applications, and proper use of bioimpedance analysers. Insufficient training on device operation, data interpretation, and clinical applications may impede effective utilization and integration of bioimpedance analysis into healthcare practice and wellness programs, hindering market expansion.

Key players in the market are focusing on new developments and quality control to expand their reach across the world. Leading companies are investing in research and development to find new and efficient solutions to stay ahead of the competition in the market. For instance, in March 2024, Amazfit, a global leader in wearable technology announced the launch of the Amazfit Body Composition Analyzer Mat, an innovative accessory designed to complement the Amazfit Balance, known for its ability to measure eight body composition metrics from the wrist. This cutting-edge mat enhances the capabilities of the Amazfit Balance by providing users with a comprehensive full-body composition analysis. Similarly, in August 2023, Samsung launched a new Galaxy watch having Bioelectrical Impedance Analysis (or BIA) sensor which allows customer to accurately measure body composition including details such as your body fat percentage, body water content, and skeletal muscle mass. In the same way, in April 2024, ASUS announced launch of Vivo Watch 6 that utilizes Bioelectrical Impedance Analysis (BIA) technology through its electrical sensor to measure the wearer's body composition, including body fat percentage, hydration level, skeletal muscle mass, basal metabolic rate, and more consistently. Many US Defence agencies are also using bioimpedance analysers while recruiting the staff. For instance, in January 2023, InBody announced to deliver their body composition analysis devices to U.S. Marine Corps. Decades after implementing service-wide body composition standards to measure Marines’ readiness, the U.S. Marine Corps decided to refine their current body composition assessment method using the InBody 770, one of InBody’s professional body composition analysers.

North America is expected to dominate the market in the upcoming years owing to various factors, such as increases in obesity rates, increasing healthcare spending, a growing number of fitness centers and health clubs, and an increasing obese population. The growing obese population who are more likely to develop diabetes, cardiovascular diseases, and others are expected to increase the demand for assessing body composition for further treatment, thereby boosting the market growth. For instance, in the report published by National Institute of Health 2022, 1 in 3 adults were overweight and 2 in 5 adults were obese. Similarly, in the report published by National Library of Medicine, one in every two persons, more than 20 years of age, in the USA has hypertension out of which 39% of individuals have hypertension due to obesity. Furthermore, the article published in Nature Journals in April 2021 mentioned that the prevalence of metabolic disorder syndromes in Canada was 25% in 2021. Such a high prevalence of metabolic disorders is expected to contribute to the demand for bioimpedance analysers, thereby contributing to the growth of the market in this region.